HCL Technologies has announced results for Q2 FY2021, for the period ending September 30, 2020.
Q2 FY21
- Revenues were $2,506.7m, up 0.8% y/y, down 0.4% in CC
- Operating income (EBIT) was $641.6m, a margin of 21.6%, up 165bps y/y.
Q2 FY21 revenue share by service line (with estimated revenue) and CC y/y growth is:
- IT and Business Services 70.8% ($1,774m) -1.6%
- Engineering and R&D services 15.7% ($394m, -6.2%) -6.8%
- Products & Platforms 13.5% ($338m) +16.2%.
Q2 FY21 revenue by Mode 1/2/3 and CC y/y growth is:
- Mode 1, $1,587m, -6.2%
- Mode 2, $524m, +14.7%
- Mode 3, $39m, +7.6%.
Q2 FY21 EBIT margin by Mode 1/2/3 was:
- Mode 1, 20.9%
- Mode 2, 18.5% (up 450 bps y/y)
- Mode 3, 28.7%.
Q2 FY21 revenue share by region (with estimated revenue) and CC y/y growth is:
- Americas 63.1% ($1,582m) -1.3%
- Europe 28.4% ($712m), -2.6%
- RoW 8.5% ($213m), +15.3%.
Q2 FY21 revenue share by sector (with estimated revenue) and CC y/y growth is:
- Financial Services 22.1% ($554m) -2.5%
- Manufacturing 17.7% ($444m) -11.3%
- Technology & Services 17.3% ($434m) +12.8%
- Retail & CPG 10.4% ($261m) +3.3%
- Telecom, Media, Publishing & Entertainment 7.7% ($193m) -8.8%
- Life Sciences & Healthcare 14.1% ($363m) +9.2%
- Public sector 10.7% ($268m) -3.0%.
LTM key client contribution to revenue (and at end Q1 FY21) was:
- Top 5: 13.7% (13.9%)
- Top 10: 20.9% (20.9%)
- Top 20: 30.6% (30.8%)
The number of large accounts (and y/y change) was:
- $100m+ 14 (+1)
- $50m+ 29 (-1)
- $10m+ 172 (+1)
HCL signed 15 transformational deals in Q2 led by the Life Sciences and Healthcare, Public Services and Manufacturing.
Total headcount at end September 2020 was 153,085, a net increase of 2,798 during the quarter, and a growth of 4.1% y/y.
LTM attrition in IT services was 12.2%, down from 16.9% in Q1 FY20.
Vendor | HCL Technologies |
Initial currency type (specify local currency used) | US$ |
Period Ending | 2020-09-30 |
Growth | 0.8 |
Revenues ((m) in local currency | 2506.7 |
Revenues (in $m at that date) | 2506.7 |